The other study that enrolled a sample from the same demographic subset of postmenopausal women with overweight or obesity only measured CRP and showed a statistically significant reduction in this marker in the intervention group compared to placebo. This evidence concerns the gene CRP and obesity due to melanocortin 4 receptor deficiency.